“Perhaps the timing caught some of you by surprise because we didn’t engage in the drama of a public horse race for succession that some of our competitors have been involved in,” Wyeth CEO and short-timer Robert Essner told analysts this morning during an earnings call. He was comparing his company’s...
read more
Merck’s diabetes drug Januvia has been approved by the FDA for use in combination with older diabetes medicines, but stiffer warnings have also been added to the Januvia’s label. The instructions now say allergic reactions and cases of a rare skin called Stevens-Johnson syndrome have been reported in some patients taking...
read more
Delirium often dogs patients after they’ve been released from intensive care. The health community has long seen the confusion and cognitive impairmant as temporary, and more or less inevitable, complications that aren’t particularly serious. Yet a growing body of research suggests that an episode of delirium in the...
read more
In these days of drug-industry troubles, who but Genentech could beat estimates, post 22% year-over-year earnings growth and still disappoint Wall Street? Here’s what a few of the Genentech watchers had to say: “2007 Has Been Remarkable Only For The Deceleration In Growth,” reads one of the bullet-points from...
read more
As the reign of Pfizer CEO Hank McKinnell was entering its twilight almost two years ago, he fired off a short, internal email asking whether it was time to buy Biogen Idec, the Health Blog has learned. The answer to the query from McKinnell (pictured) turned out to be “no,” as history shows. But his question and the...
read moreThe deadly H5N1 bird flu virus can pass through the placenta of pregnant women and into the fetus, Chinese scientists report.
read more
Recent Comments